Our team has a wealth of experience and expertise in the development of protein/peptide therapeutics and an in-depth understanding of the needs of the pharmaceutical industry when it comes to the development and manufacture of novel, effective and safe biologics. In addition, with our business acumen and experience of forming strategic alliances we are working to build effective partnerships to deliver biologics solutions:
Alan Lamb | Non-Exec Director
Alan has broad experience as director, manager and entrepreneur in technology businesses from early stage through to being part of a large public company. He founded Flexion, Inc. with venture capital backing in 1998 to provide new generation communication systems for smaller businesses. In the last 12 years he has focused on developing spin-out companies from UK universities as a mentor, chairman and non-executive director. He formed Blaze Photonics which was sold to Crystal Fibre, and Identum which was sold to Trend Micro. He is on the board of Promethean Particles, a supplier of specialist nano-particles, and is chairman of Gyrometric Systems who provide measurement systems to predict failure in rotating shafts. He is an independent director of Kings Arms Yard VCT plc and is a nonexecutive director of Resilient Networks plc. Alan was appointed Non-Exec Director of Glythera last March 2014.